Phillips-Medisize wins contract to manufacture electronic drug delivery device

Phillips-Medisize, a Molex company, announced an agreement with a leading biotechnology company to manufacture a wearable, electronic-enabled combination drug delivery product, pending FDA approval, with launch slated for 2H 2020.

“This exciting new contract taps over 13 years of Phillips-Medisize's combination product expertise, which includes cold chain drug handling and first programs with API handling.”phillipsmedisize.com

• 1 source
• phillipsmedisize.comPhillips-Medisize Wins Contract to Manufacture First Electronic-Enabled Combination Drug Delivery Product | Phillips MedisizeOct 22, 2019

Summarized from public sources; check the original articles before acting on it.